US Stock MarketDetailed Quotes

XENE Xenon Pharmaceuticals

Watchlist
  • 42.340
  • +0.340+0.81%
Trading Dec 4 14:46 ET
3.23BMarket Cap-15067P/E (TTM)

Xenon Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
0
0
0
0
0
0
0
0
-48.83%9.43M
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
-48.83%9.43M
--0
Cost of revenue
Gross profit
Operating expense
32.31%73.68M
24.23%69.1M
20.37%59.04M
54.47%214.05M
23.92%53.7M
45.54%55.68M
80.30%55.62M
87.68%49.05M
42.23%138.58M
51.64%43.33M
Selling and administrative expenses
30.47%16.71M
67.49%19.4M
55.12%14.79M
41.85%46.54M
48.44%12.62M
45.02%12.8M
33.07%11.58M
40.74%9.54M
49.36%32.81M
27.11%8.5M
-General and administrative expense
30.47%16.71M
67.49%19.4M
55.12%14.79M
41.85%46.54M
48.44%12.62M
45.02%12.8M
33.07%11.58M
40.74%9.54M
49.36%32.81M
27.11%8.5M
Research and development costs
32.86%56.97M
12.86%49.7M
11.98%44.25M
58.38%167.51M
17.93%41.08M
45.70%42.88M
98.86%44.04M
104.11%39.52M
40.16%105.77M
59.14%34.83M
Operating profit
-32.31%-73.68M
-24.23%-69.1M
-20.37%-59.04M
-65.75%-214.05M
-23.92%-53.7M
-46.04%-55.68M
-83.49%-55.62M
-182.41%-49.05M
-63.49%-129.14M
-74.45%-43.33M
Net non-operating interest income expense
47.94%10.33M
66.11%10.84M
109.39%11.36M
217.00%27.62M
94.73%8.69M
127.72%6.98M
699.51%6.52M
1,373.64%5.42M
1,769.74%8.71M
2,236.65%4.46M
Non-operating interest income
47.94%10.33M
66.11%10.84M
109.39%11.36M
217.00%27.62M
94.73%8.69M
127.72%6.98M
699.51%6.52M
1,373.64%5.42M
1,769.74%8.71M
2,236.65%4.46M
Other net income (expense)
185.54%237K
-99.30%10K
-92.38%167K
177.70%3.75M
-97.86%56K
103.10%83K
183.52%1.42M
171.53%2.19M
-1,236.57%-4.83M
703.23%2.61M
Gain on sale of security
185.54%237K
-99.30%10K
-92.38%167K
177.70%3.75M
-97.86%56K
103.10%83K
183.52%1.42M
171.53%2.19M
-1,236.57%-4.83M
703.23%2.61M
Income before tax
-29.81%-63.11M
-22.18%-58.26M
-14.68%-47.52M
-45.85%-182.69M
-23.97%-44.95M
-28.84%-48.62M
-52.83%-47.68M
-106.52%-41.44M
-58.78%-125.26M
-44.56%-36.26M
Income tax
-103.82%-320K
-51.36%-333K
42.07%412K
-347.46%-292K
-118.00%-205K
73.25%-157K
-450.00%-220K
173.60%290K
2,066.67%118K
135.33%1.14M
Net income
-29.57%-62.79M
-22.05%-57.92M
-14.87%-47.93M
-45.48%-182.39M
-19.65%-44.74M
-30.45%-48.46M
-52.32%-47.46M
-112.14%-41.73M
-58.94%-125.37M
-46.28%-37.4M
Net income continuous Operations
-29.57%-62.79M
-22.05%-57.92M
-14.87%-47.93M
-45.48%-182.39M
-19.65%-44.74M
-30.45%-48.46M
-52.32%-47.46M
-112.14%-41.73M
-58.94%-125.37M
-46.28%-37.4M
Minority interest income
Net income attributable to the parent company
-29.57%-62.79M
-22.05%-57.92M
-14.87%-47.93M
-45.48%-182.39M
-19.65%-44.74M
-30.45%-48.46M
-52.32%-47.46M
-112.14%-41.73M
-58.94%-125.37M
-46.28%-37.4M
Preferred stock dividends
75.65%-437K
96.51%-17K
Other preferred stock dividends
Net income attributable to common stockholders
-29.57%-62.79M
-22.05%-57.92M
-14.87%-47.93M
-45.99%-182.39M
-19.70%-44.74M
-30.45%-48.46M
-52.32%-47.46M
-115.41%-41.73M
-62.07%-124.94M
-49.05%-37.38M
Basic earnings per share
-10.96%-0.81
-4.17%-0.75
1.59%-0.62
-32.52%-2.73
-12.28%-0.64
-28.07%-0.73
-30.91%-0.72
-80.00%-0.63
-16.38%-2.06
-18.75%-0.57
Diluted earnings per share
-10.96%-0.81
-4.17%-0.75
1.59%-0.62
-32.52%-2.73
-12.28%-0.64
-28.07%-0.73
-30.91%-0.72
-80.00%-0.63
-16.38%-2.06
-18.75%-0.57
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue 00000000-48.83%9.43M0
Operating revenue --0--0--0--0--0--0--0--0-48.83%9.43M--0
Cost of revenue
Gross profit
Operating expense 32.31%73.68M24.23%69.1M20.37%59.04M54.47%214.05M23.92%53.7M45.54%55.68M80.30%55.62M87.68%49.05M42.23%138.58M51.64%43.33M
Selling and administrative expenses 30.47%16.71M67.49%19.4M55.12%14.79M41.85%46.54M48.44%12.62M45.02%12.8M33.07%11.58M40.74%9.54M49.36%32.81M27.11%8.5M
-General and administrative expense 30.47%16.71M67.49%19.4M55.12%14.79M41.85%46.54M48.44%12.62M45.02%12.8M33.07%11.58M40.74%9.54M49.36%32.81M27.11%8.5M
Research and development costs 32.86%56.97M12.86%49.7M11.98%44.25M58.38%167.51M17.93%41.08M45.70%42.88M98.86%44.04M104.11%39.52M40.16%105.77M59.14%34.83M
Operating profit -32.31%-73.68M-24.23%-69.1M-20.37%-59.04M-65.75%-214.05M-23.92%-53.7M-46.04%-55.68M-83.49%-55.62M-182.41%-49.05M-63.49%-129.14M-74.45%-43.33M
Net non-operating interest income expense 47.94%10.33M66.11%10.84M109.39%11.36M217.00%27.62M94.73%8.69M127.72%6.98M699.51%6.52M1,373.64%5.42M1,769.74%8.71M2,236.65%4.46M
Non-operating interest income 47.94%10.33M66.11%10.84M109.39%11.36M217.00%27.62M94.73%8.69M127.72%6.98M699.51%6.52M1,373.64%5.42M1,769.74%8.71M2,236.65%4.46M
Other net income (expense) 185.54%237K-99.30%10K-92.38%167K177.70%3.75M-97.86%56K103.10%83K183.52%1.42M171.53%2.19M-1,236.57%-4.83M703.23%2.61M
Gain on sale of security 185.54%237K-99.30%10K-92.38%167K177.70%3.75M-97.86%56K103.10%83K183.52%1.42M171.53%2.19M-1,236.57%-4.83M703.23%2.61M
Income before tax -29.81%-63.11M-22.18%-58.26M-14.68%-47.52M-45.85%-182.69M-23.97%-44.95M-28.84%-48.62M-52.83%-47.68M-106.52%-41.44M-58.78%-125.26M-44.56%-36.26M
Income tax -103.82%-320K-51.36%-333K42.07%412K-347.46%-292K-118.00%-205K73.25%-157K-450.00%-220K173.60%290K2,066.67%118K135.33%1.14M
Net income -29.57%-62.79M-22.05%-57.92M-14.87%-47.93M-45.48%-182.39M-19.65%-44.74M-30.45%-48.46M-52.32%-47.46M-112.14%-41.73M-58.94%-125.37M-46.28%-37.4M
Net income continuous Operations -29.57%-62.79M-22.05%-57.92M-14.87%-47.93M-45.48%-182.39M-19.65%-44.74M-30.45%-48.46M-52.32%-47.46M-112.14%-41.73M-58.94%-125.37M-46.28%-37.4M
Minority interest income
Net income attributable to the parent company -29.57%-62.79M-22.05%-57.92M-14.87%-47.93M-45.48%-182.39M-19.65%-44.74M-30.45%-48.46M-52.32%-47.46M-112.14%-41.73M-58.94%-125.37M-46.28%-37.4M
Preferred stock dividends 75.65%-437K96.51%-17K
Other preferred stock dividends
Net income attributable to common stockholders -29.57%-62.79M-22.05%-57.92M-14.87%-47.93M-45.99%-182.39M-19.70%-44.74M-30.45%-48.46M-52.32%-47.46M-115.41%-41.73M-62.07%-124.94M-49.05%-37.38M
Basic earnings per share -10.96%-0.81-4.17%-0.751.59%-0.62-32.52%-2.73-12.28%-0.64-28.07%-0.73-30.91%-0.72-80.00%-0.63-16.38%-2.06-18.75%-0.57
Diluted earnings per share -10.96%-0.81-4.17%-0.751.59%-0.62-32.52%-2.73-12.28%-0.64-28.07%-0.73-30.91%-0.72-80.00%-0.63-16.38%-2.06-18.75%-0.57
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Symbol Mini Chart % Chg
Salesforce
CRM
+9.23%
Coinbase
COIN
+5.59%
Adobe
ADBE
+3.92%
Oracle
ORCL
+3.01%
MicroStrategy
MSTR
+2.96%

Unlock the Full List